NOVEL CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR

The present invention relates to a novel crystalline form of the dihydrochloride salt of (2R,3S,5S)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tetrahydro-2H-pyran-3-amine as well as a process for its preparation, pharmaceutical compositions containing this novel form, and me...

Full description

Saved in:
Bibliographic Details
Main Authors ELLISON, MARTHA, E, WENSLOW, ROBERT, M, VARIANKAVAL, NARAYAN
Format Patent
LanguageEnglish
French
Published 29.01.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a novel crystalline form of the dihydrochloride salt of (2R,3S,5S)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tetrahydro-2H-pyran-3-amine as well as a process for its preparation, pharmaceutical compositions containing this novel form, and methods of use of the novel form and pharmaceutical compositions for the treatment of Type 2 diabetes, hyperglycemia, insulin resistance, obesity, and high blood pressure. La présente invention porte sur une nouvelle forme cristalline du sel de dichlorhydrate de (2R,3S,5S)-2-(2,5-difluorophényl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tétrahydro-2H-pyran-3-amine, ainsi que sur un procédé pour sa préparation, sur des compositions pharmaceutiques contenant cette nouvelle forme et sur des procédés d'utilisation de la nouvelle forme et des compositions pharmaceutiques pour le traitement du diabète de type 2, de l'hyperglycémie, de la résistance à l'insuline, de l'obésité et de l'hypertension.
Bibliography:Application Number: WO2008US08859